Carterra 23/09/25
LB Bohle – 10.06.2025
Nipro Vialex – 26th January 2025
PCI – 7th June 2024
Temax_Krautz

Current Edition

Pharmapack 2026
SAE Media – pre-filled syringes EU 19/11/25
Terumo 05/01
SAE Media – pre-filled syringes – East Coast 19/11/25
Novo Nordisk 20 March 2024, 11:21
Carterra – 24th March 2025

User Testing: Critical for Truly Understanding Patient Needs

Ophthalmic pathologies include eyesight-threatening conditions (diabetic retinopathy, glaucoma, cataract, age-related macular degeneration and retinal detachment) and, relatively speaking, less serious eye conditions (dry eye, red eye, etc.), all of which are treated by ocular injections, eyedrops or surgery. Eyedrops are primarily used for glaucoma, dry eye disease (DED), conjunctivitis and allergy. Fanny Sellier of Nemera explains why, for chronic diseases, when daily treatments are needed, preservative-free formulations are key to protecting the patient’s ocular surface, as preservatives can cause allergic reactions and irritations, and can even damage patients’ eyes.

 

Nipro – 07/01/2026
YPSOMED website ad
Scott Pharma – 25.03.2025
Bespak – 21.05.2025
SAE Media – AI in DD
HCMed
Woolcool 26 March 2024, 16:16
Biopharma group 6 March 2024, 09:40
Aptar – 08/01/2026
Nipro – 09.06.2025
Stoelzle – 15th May 2025
L.B. Bohle – 08.04.2025